Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 16, 2021
Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective Study
Pedro Ls Uson Junior, Katie L Kunze, Michael A Golafshar, et al.
Translational Gastroenterology and Hepatology
|
June 15, 2026
Landscape of clinical trials and impact of precision medicine in biliary tract cancers in the last 45 years: a systematic review and meta-analysis of biomarker-driven trials
Pedro Luiz Serrano Uson Junior, Fernando Moura, Frederico Monfardini, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
December 1, 2018
Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer
Mitchell L Ramsey, Erin Talbert, Daniel Ahn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 5, 2016
Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma
Anne M Noonan, Matthew R Farren, Susan M Geyer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 15, 2021
Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study
Pedro L S Uson, Douglas Riegert-Johnson, Lisa Boardman, et al.
JAMA Network Open
|
September 12, 2025
Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors
Himil Mahadevia, Umair Majeed, Jaydeepbhai Patel, et al.
The New England Journal of Medicine
|
January 18, 2023
Futibatinib for <i>FGFR2</i>-Rearranged Intrahepatic Cholangiocarcinoma
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.
The Oncologist
|
September 19, 2025
First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective study
Ioannis Kournoutas, Paulina Marell, Jennifer Gile, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 16, 2021
Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective Study
Pedro Ls Uson Junior, Katie L Kunze, Michael A Golafshar, et al.
Translational Gastroenterology and Hepatology
|
June 15, 2026
Landscape of clinical trials and impact of precision medicine in biliary tract cancers in the last 45 years: a systematic review and meta-analysis of biomarker-driven trials
Pedro Luiz Serrano Uson Junior, Fernando Moura, Frederico Monfardini, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
December 1, 2018
Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer
Mitchell L Ramsey, Erin Talbert, Daniel Ahn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 5, 2016
Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma
Anne M Noonan, Matthew R Farren, Susan M Geyer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 15, 2021
Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study
Pedro L S Uson, Douglas Riegert-Johnson, Lisa Boardman, et al.
JAMA Network Open
|
September 12, 2025
Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors
Himil Mahadevia, Umair Majeed, Jaydeepbhai Patel, et al.
The New England Journal of Medicine
|
January 18, 2023
Futibatinib for <i>FGFR2</i>-Rearranged Intrahepatic Cholangiocarcinoma
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.
The Oncologist
|
September 19, 2025
First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective study
Ioannis Kournoutas, Paulina Marell, Jennifer Gile, et al.
Page
of 6